This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Steven E Ealick: Innovator in Pharmaceutical Chemistry
Introduction
Steven E Ealick is a notable inventor in the field of pharmaceutical chemistry. He has contributed to the development of compounds that serve as purine nucleoside phosphorylase inhibitors. His work is significant in the context of drug discovery and development.
Latest Patents
Ealick holds a patent for "9-Substituted-8-Unsubstituted-9-Deazaguanines." The specification discloses compounds of formula (1), wherein (a) -CH2Ar represents formula .alpha., with R1 and R2 representing various chemical groups. These compounds are essential in the development of inhibitors that target specific enzymes.
Career Highlights
Throughout his career, Ealick has worked with various companies, including John A. Secrist III and Mark D. Erion. His collaborations have allowed him to advance his research and contribute to the scientific community.
Collaborations
Ealick has collaborated with notable individuals such as John A. Secrist III and Mark D. Erion. These partnerships have played a crucial role in his research endeavors.
Conclusion
Steven E Ealick is a significant figure in pharmaceutical chemistry, with a focus on developing innovative compounds. His contributions to the field are noteworthy, and his work continues to impact drug discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile